Restricted accessResearch articleFirst published online 2022-12
Neuroprotective Potential of Hydroalcoholic Extract of Centella asiatica Against 3-Nitropropionic Acid-Induced Huntington's Like Symptoms in Adult Zebrafish
Huntington's disease (HD) is an inherited neurodegenerative disease. 3-Nitropropionic acid (3-NP) causes increased reactive oxygen species production and neuroinflammation. Centella asiatica (CA) is a strong antioxidant. The aim of this study is to investigate the effect of hydroalcoholic extract of C. asiatica (HA-CA) on 3-NP-induced HD in adult zebrafish. Adult zebrafish (∼5–6 months old) weighing 470 to 530 mg was used and treated with 3-NP (5 mg/kg intraperitoneal [i.p.]). The animals received HA-CA (80 and 100 mg/L) daily for up to 28 days in water. Tetrabenazine (3 mg/kg i.p.) was used as a standard drug. We have done an open field test (for locomotor activity), a novel tank diving test (for anxiety), and a light and dark tank test (for memory), followed by biochemical analysis (acetyl-cholinesterase [AchEs], nitrite, lipid peroxidation [LPO], and glutathione [GSH]) and histopathology to further confirm memory dysfunctions. 3-NP-treated zebrafish exhibit reductions in body weight, progressive neuronal damage, cognition, and locomotor activity. The HA-CA group significantly reduced the 3-NP-induced increase in LPO, AchEs, and nitrite levels while decreasing GSH levels. Oral administration of HA-CA (80 or 100 mg/L) significantly reduces 3-NP-induced changes in body weight and behaviors, in addition to neuroinflammation in the brain by lowering tumor necrosis factor-α and interleukin-1β levels. Moreover, HA-CA significantly decreases the 3-NP-induced neuronal damage in the brain. HA-CA ameliorates neurotoxicity and neurobehavioral deficits in 3-NP-induced HD-like symptoms in adult zebrafish.
Get full access to this article
View all access options for this article.
References
1.
KaurN, JamwalS, DeshmukhR, et al.Beneficial effect of rice bran extract against 3-nitropropionic acid induced experimental Huntington's disease in rats. Toxicol Rep, 2015; 2:1222–1232.
2.
BaigSS, StrongM, QuarrellOW. The global prevalence of Huntington's disease: A systematic review and discussion. Neurodegener Dis Manage, 2016; 6:331–343.
3.
TabriziSJ, FlowerMD, RossCA, WildEJ. Huntington disease: New insights into molecular pathogenesis and therapeutic opportunities. Nat Rev Neurol, 2020; 16:529–546.
4.
KumarV, KunduS, SinghA, SinghS. Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: Current targets and future perspective. Curr Neuropharmacol, 2022; 20:158–178.
5.
ReuterI, TaiYF, PaveseN, et al.Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease. J Neurol Neurosurg Psychiatry, 2008; 79:948–951.
6.
ChakrabortyJ, Nthenge-NgumbauD, RajammaU, MohanakumarK. Melatonin protects against behavioural dysfunctions and dendritic spine damage in 3-nitropropionic acid-induced rat model of Huntington's disease. Behav Brain Res, 2014; 264:91–104.
7.
KumarV, SinghC, SinghA. Zebrafish an experimental model of Huntington's disease: Molecular aspects, therapeutic targets and current challenges. Mol Biol Rep, 2021; 48:8181–8194.
8.
KumarV, KaurS, KapilL, et al.HDAC11: A novel inflammatory biomarker in Huntington's disease. EXCLI J, 2022; 21:647.
GaoY, ChuS-F, LiJ-P, et al.Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease. Acta Pharmacol Sin, 2015; 36:311–322.
11.
KumarV, SinghA. Targeting N17 domain as a potential therapeutic target for the treatment of Huntington disease: An opinion. EXCLI J, 2021; 20:1086.
MuS, LinE, LiuB, et al.Melatonin reduces projection neuronal injury induced by 3-nitropropionic acid in the rat striatum. Neurodegener Dis, 2014; 14:139–150.
14.
WiprichMT, ZanandreaR, AltenhofenS, BonanCD. Influence of 3-nitropropionic acid on physiological and behavioral responses in zebrafish larvae and adults. Comp Biochem Physiol Part C Toxicol Pharmacol, 2020; 234:108772.
15.
GoldsmithP. Zebrafish as a pharmacological tool: The how, why and when. Curr Opin Pharmacol, 2004; 4:504–512.
16.
BhattaraiP, CosacakMI, MashkaryanV, et al.Neuron-glia interaction through Serotonin-BDNF-NGFR axis enables regenerative neurogenesis in Alzheimer's model of adult zebrafish brain. PLoS Biol, 2020; 18:e3000585.
17.
WangY, LiuW, YangJ, et al.Parkinson's disease-like motor and non-motor symptoms in rotenone-treated zebrafish. Neurotoxicology, 2017; 58:103–109.
18.
HuL, GuangC, LiuY, et al.Adsorption behavior of dyes from an aqueous solution onto composite magnetic lignin adsorbent. Chemosphere, 2020; 246:125757.
19.
CanzianJ, FranscesconF, MüllerTE, et al.Stress increases susceptibility to pentylenetetrazole-induced seizures in adult zebrafish. Epilepsy Behav, 2021; 114:107557.
20.
ZhangR, ZhaoT, ZhengB, et al.Curcumin derivative Cur20 attenuated cerebral ischemic injury by antioxidant effect and HIF-1α/VEGF/TFEB-activated angiogenesis. Front Pharmacol, 2021; 12:648107.
21.
BishirM, AslamM, BhatA, et al.Acetylsalicylic acid improves cognitive performance in sleep deprived adult Zebrafish (Danio rerio) model. Front Biosci (Landmark Ed), 2021; 26:114–124.
22.
KimS, LeeD-W, SchachnerM, ParkH-C. Small compounds mimicking the adhesion molecule L1 improve recovery in a zebrafish demyelination model. Sci Rep, 2021; 11:1–10.
23.
ChengF, De LucaA, HoganAL, et al.Unbiased label-free quantitative proteomics of cells expressing amyotrophic lateral sclerosis (ALS) mutations in CCNF reveals activation of the apoptosis pathway: A workflow to screen pathogenic gene mutations. Front Mol Neurosci, 2021; 14:627740.
24.
HentigJ, CloghessyK, DunseathC, HydeDR. A scalable model to study the effects of blunt-force injury in adult zebrafish. J Vis Exp, 2021; 171:e62709.
25.
SinghB, RastogiRP. A reinvestigation of the triterpenes of Centella asiatica. Phytochemistry, 1969; 8:917–921.
26.
BrinkhausB, LindnerM, SchuppanD, HahnE. Chemical, pharmacological and clinical profile of the East Asian medical plant Centella aslatica. Phytomedicine, 2000; 7:427–448.
27.
Veerendra KumarM, GuptaY. Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats. Clin Exp Pharmacol Physiol, 2003; 30:336–342.
28.
KhotimahH, YuliyaniT, NuraenahE, et al.Centella asiatica increased the body length through the modulation of antioxidant in rotenone-induced zebrafish larvae. Biomed Pharmacol J, 2018; 11:827–833.
29.
NaßJ, KampfCJ, EfferthT. Increased stress resistance and lifespan in Chaenorhabditis elegans wildtype and knockout mutants—Implications for depression treatment by medicinal herbs. Molecules, 2021; 26:1827.
30.
CrimMJ, LawrenceC, LivingstonRS, et al.Comparison of antemortem and environmental samples for zebrafish health monitoring and quarantine. J Am Assoc Lab Anim Sci, 2017; 56:412–424.
31.
RamanathanM, SivakumarS, AnandvijayakumarP, et al.Neuroprotective evaluation of standardized extract of Centella asciatica in monosodium glutamate treated rats. Indian J Exp Biol, 2007; 45:425–431.
32.
MatthewsM, VargaZM. Anesthesia and euthanasia in zebrafish. ILAR J, 2012; 53:192–204.
33.
StewartA, WuN, CachatJ, et al.Pharmacological modulation of anxiety-like phenotypes in adult zebrafish behavioral models. Prog Neuropsychopharmacol Biol Psychiatry, 2011; 35:1421–1431.
34.
SinghS, SahuK, KapilL, et al.Quercetin ameliorates lipopolysaccharide-induced neuroinflammation and oxidative stress in adult zebrafish. Mol Biol Rep, 2022; 49:3247–3258.
35.
EganRJ, BergnerCL, HartPC, et al.Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav Brain Res, 2009; 205:38–44.
36.
BencanZ, SledgeD, LevinED. Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety. Pharmacol Biochem Behav, 2009; 94:75–80.
37.
CarolaV, D'OlimpioF, BrunamontiE, et al.Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice. Behav Brain Res, 2002; 134:49–57.
38.
GerlaiR, CrusioWE, CsányiV. Inheritance of species-specific behaviors in the paradise fish (Macropodus opercularis): A diallel study. Behav Genet, 1990; 20:487–498.
39.
BlaserR, GerlaiR. Behavioral phenotyping in zebrafish: Comparison of three behavioral quantification methods. Behav Res Methods, 2006; 38:456–469.
40.
GuptaT, MullinsMC. Dissection of organs from the adult zebrafish. J Vis Exp, 2010; 37:e1717.
41.
AgG, CJB, MMD. Determination of serum proteins by means of the biuret reaction. J Biol Chem, 1949; 177:751–766.
42.
WillsE. Mechanisms of lipid peroxide formation in animal tissues. Biochem J, 1966; 99:667.
43.
GreenLC, WagnerDA, GlogowskiJ, et al.Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem, 1982; 126:131–138.
44.
EllmanGL, CourtneyKD, Andres JrV, FeatherstoneRM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol, 1961; 7:88–95.
GalpernW, CudkowiczM. Coenzyme Q treatment of neurodegenerative diseases of aging. Mitochondrion, 2007; 7:S146-S1532007.
47.
KumarP, KaloniaH, KumarA. Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity. Eur J Pharmacol, 2012; 674:265–274.
48.
La FontaineMA, GeddesJW, BanksA, ButterfieldDA. 3-Nitropropionic acid induced in vivo protein oxidation in striatal and cortical synaptosomes: Insights into Huntington's disease. Brain Res, 2000; 858:356–362.
49.
BealMF, BrouilletE, JenkinsBG, et al.Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci, 1993; 13:4181–4192.
50.
EhrlichME. Huntington's disease and the striatal medium spiny neuron: Cell-autonomous and non-cell-autonomous mechanisms of disease. Neurotherapeutics, 2012; 9:270–284.
51.
ChenY, HanT, RuiY, et al.Effects of total triterpenes of Centella asiatica on the corticosterone levels in serum and contents of monoamine in depression rat brain. Zhong Yao Cai, 2005; 28:492–496.
52.
GanachariM, BabuV, KatareS. Neuropharmacology of an extract derived from Centella asiatica. Pharm Biol, 2004; 42:246–252.
53.
ColleD, SantosDB, MoreiraELG, et al.Probucol increases striatal glutathione peroxidase activity and protects against 3-nitropropionic acid-induced pro-oxidative damage in rats. PLoS One, 2013; 8:e67658.
54.
LevinED. Zebrafish assessment of cognitive improvement and anxiolysis: Filling the gap between in vitro and rodent models for drug development. Rev Neurosci, 2011; 22:75–84.
55.
EppingEA, PaulsenJS. Depression in the early stages of Huntington disease. Neurodegener Dis Manag, 2011; 1:407–414.
56.
MezzomoNJ, SilveiraA, GiulianiGS, et al.The role of taurine on anxiety-like behaviors in zebrafish: A comparative study using the novel tank and the light–dark tasks. Neurosci Lett, 2016; 613:19–24.
57.
PengX, LinJ, ZhuY, et al.Anxiety-related behavioral responses of pentylenetetrazole-treated zebrafish larvae to light-dark transitions. Pharmacol Biochem Behav, 2016; 145:55–65.
58.
YangL, WangJ, WangD, et al.Delayed behavioral and genomic responses to acute combined stress in zebrafish, potentially relevant to PTSD and other stress-related disorders: Focus on neuroglia, neuroinflammation, apoptosis and epigenetic modulation. Behav Brain Res, 2020; 389:112644.
59.
CsányiV, GerlaiR. Open-field behavior and the behavior-genetic analysis of the paradise fish (Macropodus opercularis). J Comp Psychol, 1988; 102:326.
60.
EchevarriaDJ, HammackCM, PrattDW, HosemannJD. A novel behavioral test battery to assess global drug effects using the zebrafish. Int J Comp Psychol, 2008; 21:19–34.
61.
StewartAM, GaikwadS, KyzarE, KalueffAV. Understanding spatio-temporal strategies of adult zebrafish exploration in the open field test. Brain Res, 2012; 1451:44–52.
StackEC, MatsonWR, FerranteRJ. Evidence of oxidant damage in Huntington's disease: Translational strategies using antioxidants. Ann N Y Acad Sci, 2008; 1147:79–92.
64.
GoswamiA, DikshitP, MishraA, et al.Oxidative stress promotes mutant huntingtin aggregation and mutant huntingtin-dependent cell death by mimicking proteasomal malfunction. Biochem Biophys Res Commun, 2006; 342:184–190.
65.
PradoVF, Martins-SilvaC, de CastroBM, et al.Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron, 2006; 51:601–612.
66.
DaiJ, BuijsRM, KamphorstW, SwaabDF. Impaired axonal transport of cortical neurons in Alzheimer's disease is associated with neuropathological changes. Brain Res, 2002; 948:138–144.
67.
KumarP, KumarA. Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain. Prog Neuropsychopharmacol Biol Psychiatry, 2009; 33:100–108.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
